Adult urological soft tissue sarcomas: A multicenter study of the anatolian society of medical oncology (ASMO)

Simple item page
dc.contributor.authorUnal O.U.
dc.contributor.authorOztop I.
dc.contributor.authorMenekse S.
dc.contributor.authorUrakci Z.
dc.contributor.authorBozkurt O.
dc.contributor.authorOzcelik M.
dc.contributor.authorGunaydin Y.
dc.contributor.authorYasar N.
dc.contributor.authorYazilitas D.
dc.contributor.authorKodaz H.
dc.contributor.authorTaskoylu B.Y.
dc.contributor.authorAksoy A.
dc.contributor.authorDemirci U.
dc.contributor.authorAraz M.
dc.contributor.authorTonyali O.
dc.contributor.authorSevinc A.
dc.contributor.authorYilmaz A.U.
dc.contributor.authorBenekli M.
dc.date.accessioned2024-07-22T08:14:12Z
dc.date.available2024-07-22T08:14:12Z
dc.date.issued2015
dc.description.abstractObjective: To analyze clinicopathological characteristics, prognostic factors and survival rates of the patients with urological soft tissue sarcomas treated and followed up in Turkey. Materials and Methods: For overall survival analyses the Kaplan-Meier method was used. From medical records, nine prognostic factors on overall survival were analysed. Results: For the 53 patients (34 males, 19 females) whose charts were reviewed, the median age was 53 (range 22 to 83) years. Most frequently renal location (n=30; 56.6%) was evident and leiomyosarcoma (n=20, 37.7%) was the most frequently encountered histological type. Median survival time of all patients was 40.3 (95% CI, 14.2-66.3) months. In univariate analysis, male gender, advanced age (=50 years), metastatic stage, unresectability, grade 3, renal location were determined as worse prognostic factors. In multivariate analysis, metastatic stage, unresectability and grade 3 were determined as indicators of worse prognosis. Conclusions: Urological soft tissue sarcomas are rarely seen tumours in adults. The most important factors in survival are surgical resection, stage of the tumour at onset, grade and location of the tumour, gender and age of the patients.
dc.identifier.DOI-ID10.7314/APJCP.2015.16.11.4777
dc.identifier.issn15137368
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/16511
dc.language.isoEnglish
dc.publisherAsian Pacific Organization for Cancer Prevention
dc.rightsAll Open Access; Gold Open Access; Green Open Access
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectFemale
dc.subjectFollow-Up Studies
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectNeoplasm Grading
dc.subjectNeoplasm Metastasis
dc.subjectNeoplasm Staging
dc.subjectPrognosis
dc.subjectSarcoma
dc.subjectSurvival Rate
dc.subjectUrologic Neoplasms
dc.subjectYoung Adult
dc.subjectadult
dc.subjectaged
dc.subjectcancer grading
dc.subjectcancer staging
dc.subjectclinical trial
dc.subjectfemale
dc.subjectfollow up
dc.subjecthuman
dc.subjectmale
dc.subjectmetastasis
dc.subjectmiddle aged
dc.subjectmortality
dc.subjectmulticenter study
dc.subjectpathology
dc.subjectprognosis
dc.subjectsarcoma
dc.subjectsurvival rate
dc.subjectUrologic Neoplasms
dc.subjectvery elderly
dc.subjectyoung adult
dc.titleAdult urological soft tissue sarcomas: A multicenter study of the anatolian society of medical oncology (ASMO)
dc.typeArticle

Files

Collections

Scopus Koleksiyonu